Ocugen, Inc. — Director's Dealing 2015

Jun 3, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HISTOGENICS CORP (HSGX)
CIK: 0001372299
Period of Report: 2015-06-01

Reporting Person: Wilmslow Estates Ltd (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-01	Common Stock	J	89441	$0.00	Disposed	1827666	Direct

Footnotes

F1: The shares transferred in this transaction were transferred pursuant to the Yayon Agreement (as defined in the Issuer's Prospectus filed with the Securities and Exchange Commission on December 3, 2014), pursuant to which the Reporting Person was obligated to transfer the number of shares of the Issuer's Common Stock described herein to Professor Avner Yayon in satisfaction of the Reporting Person's obligations under the Yayon Agreement.